Terms: = Liver cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
48 results:
1. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
Jessen M; Gertzmann D; Liss F; Zenk F; Bähner L; Schöffler V; Schulte C; Maric HM; Ade CP; von Eyss B; Gaubatz S
Oncogene; 2024 Feb; 43(8):578-593. PubMed ID: 38182898
[TBL] [Abstract] [Full Text] [Related]
2. CD36-BATF2\myb Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric cancer.
Jiang Q; Chen Z; Meng F; Zhang H; Chen H; Xue J; Shen X; Liu T; Dong L; Zhang S; Xue R
Int J Biol Sci; 2023; 19(14):4476-4492. PubMed ID: 37781029
[TBL] [Abstract] [Full Text] [Related]
3. Inversed albumin-to-globulin ratio and underlying liver disease severity as a prognostic factor for survival in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Li J; Li Z; Hao S; Wang J; Chen W; Dai S; Hou Z; Chen B; Zhang Y; Liu D
Diagn Interv Radiol; 2023 May; 29(3):520-528. PubMed ID: 36992824
[TBL] [Abstract] [Full Text] [Related]
4. Frequent loss of metastatic ability in subclones of Apc, Kras, Tgfbr2, and Trp53 mutant intestinal tumor organoids.
Morita A; Nakayama M; Wang D; Murakami K; Oshima M
Cancer Sci; 2023 Apr; 114(4):1437-1450. PubMed ID: 36576236
[TBL] [Abstract] [Full Text] [Related]
5. Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and mybL2 on Ras/ErbB signaling.
Zhong F; Chen T; Li B
Biochem Biophys Res Commun; 2022 Sep; 622():170-176. PubMed ID: 35932528
[TBL] [Abstract] [Full Text] [Related]
6. myb proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the
Liu M; Du Q; Mao G; Dai N; Zhang F
Bioengineered; 2022 Mar; 13(3):5344-5356. PubMed ID: 35176941
[TBL] [Abstract] [Full Text] [Related]
7. Elevated expression of the myb proto-oncogene like 2 (mybL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract] [Full Text] [Related]
8. Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.
Liang J; Li G; Liao J; Huang Z; Wen J; Wang Y; Chen Z; Cai G; Xu W; Ding Z; Liang H; Datta PK; Chu L; Chen X; Zhang B
Cell Death Differ; 2022 May; 29(5):988-1003. PubMed ID: 35034103
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA lncAY is upregulated by sulfatide via myb/MEF2C acetylation to promote the tumorigenicity of hepatocellular carcinoma cells.
Chen MH; Qi B; Cai QQ; Sun JW; Fu LS; Kang CL; Fan F; Ma MZ; Wu XZ
Biochim Biophys Acta Gene Regul Mech; 2022 Jan; 1865(1):194777. PubMed ID: 34843988
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission.
Yi T; Luo H; Qin F; Jiang Q; He S; Wang T; Su J; Song S; Qin X; Qin Y; Zhou X; Huang Z
Cell Death Dis; 2020 Oct; 11(10):832. PubMed ID: 33028809
[TBL] [Abstract] [Full Text] [Related]
11. A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma.
Mahmood U; Bang A; Chen YH; Mak RH; Lorch JH; Hanna GJ; Nishino M; Manuszak C; Thrash EM; Severgnini M; Sanborn M; Sridharan V; Margalit DN; Tishler RB; Busse PM; Willers H; Mamon HJ; Yoo HJ; Pai SI; Wirth LJ; Haddad RI; Chau NG; Schoenfeld JD
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):134-144. PubMed ID: 32781104
[TBL] [Abstract] [Full Text] [Related]
12. High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cells.
Higurashi M; Maruyama T; Nogami Y; Ishikawa F; Yoshida Y; Mori K; Fujita KI; Shibanuma M
Exp Cell Res; 2020 Apr; 389(1):111889. PubMed ID: 32032602
[TBL] [Abstract] [Full Text] [Related]
13. Targeting mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5.
Weng X; Wu J; Lv Z; Peng C; Chen J; Zhang C; He B; Tong R; Hu W; Ding C; Cao L; Chen D; Wu J; Zheng S
EBioMedicine; 2019 Jun; 44():225-236. PubMed ID: 31109829
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop.
Lan T; Yuan K; Yan X; Xu L; Liao H; Hao X; Wang J; Liu H; Chen X; Xie K; Li J; Liao M; Huang J; Zeng Y; Wu H
Cancer Res; 2019 Jul; 79(13):3220-3234. PubMed ID: 31101763
[TBL] [Abstract] [Full Text] [Related]
15. YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene mybL2 and proliferation in liver cancer cells.
Wei T; Weiler SME; Tóth M; Sticht C; Lutz T; Thomann S; De La Torre C; Straub B; Merker S; Ruppert T; Marquardt J; Singer S; Gretz N; Schirmacher P; Breuhahn K
Oncogene; 2019 Jul; 38(27):5541-5550. PubMed ID: 30936457
[TBL] [Abstract] [Full Text] [Related]
16. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-myb-regulated MEK/ERK signaling.
Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
[TBL] [Abstract] [Full Text] [Related]
17. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
[TBL] [Abstract] [Full Text] [Related]
18. LINC01287 regulates tumorigenesis and invasion via miR-298/myb in hepatocellular carcinoma.
Mo Y; He L; Lai Z; Wan Z; Chen Q; Pan S; Li L; Li D; Huang J; Xue F; Che S
J Cell Mol Med; 2018 Nov; 22(11):5477-5485. PubMed ID: 30133116
[TBL] [Abstract] [Full Text] [Related]
19. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH
Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
[TBL] [Abstract] [Full Text] [Related]
20. Use of Gene Expression Analysis for Discrimination of Primary and Secondary Adenocarcinoma of the liver.
Hass HG; Vogel U; Scheurlen M; Jobst J
Oncology; 2018; 95(4):211-219. PubMed ID: 29920486
[TBL] [Abstract] [Full Text] [Related]
[Next]
